(PharmaNewsWire.Com, December 01, 2017 ) According to the report Europe HIV Diagnostics Market, published by Market Data Forecast, the global market is projected to reach USD 641.34 million by 2021, at a CAGR of 9.20% from 2016 to 2021.
HIV spreads through exchange of fluids with some infected individual, for example, blood exchange or imparting needles to somebody who is HIV infected. Additionally, HIV Diagnostics analysis can spread from infected mother to child during pregnancy. Here are some of the symptoms of HIV disease are slight fever, weakness, swollen glands, cerebral pains and muscle hurts. Integrase inhibitors section is expected to be the rapid growing class of antiretroviral medications owing to the normal dispatch of extra integrase inhibitors by major players, for example, Gilead Sciences, In., and Merck and Co., Inc.
HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete efforts from authorities and various philanthropic institutions, the numbers are still on an upward trend with a total of 33.3 Million HIV victims across the world Europe HIV Diagnostics Market: Drivers & Restraints Major factors driving the market are, the technological advancement of disease diagnostic tests, and the foreseen improvement and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests; it is expected that all the major regional market segments will witness an expansion in market demand over the forecast period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests. Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.
By Product Introduction Consumables Assays and Kits &Reagents Other Consumables Software & Services Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product
By Type Introduction Antibody Tests HIV Screening Tests HIV-1 Antibody Confirmatory Tests HIV-2 & Group O Diagnostic Tests Viral Identification Tests p24 Antigen Test Qualitative PCR Tests Viral Culture CD4 Testing Viral Load testing Early Infant Diagnostics Y-o-Y Growth Analysis, By Type Market Attractiveness Analysis, By Type Market Share Analysis, By Type
By End User Introduction Diagnostic Laboratories Hospitals Blood Banks Home Care Settings Other End Users Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User
Europe HIV Diagnostics Market: Overview The leading business intelligence provider GBI Research has released its latest research report, entitled HIV Diagnostics Market to 2019 Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline.
The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada. The report discusses the global pipeline for all the HIV molecules across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
Europe HIV Diagnostics Market: Region-wise Outlook On the basis of geography, the Europe market is analyzed under various regions namely U.K, Italy, France, Germany, and Spain. Europe is anticipated to be the fastest developing regional section and will hold its position over the forecast period inferable from the upgrading medicinal services foundation and presence of appropriate government activities favoring development.
Key Questions Answered What is the current and future Europe HIV Therapeutics Market outlook in global? What trends are affecting the Europe market? What is the competitive landscape and market share of major players in the Global HIV Therapeutics space in Europe? What are the key, high growth markets that Europe HIV Therapeutics manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Europe HIV Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Europe HIV Therapeutics? What are the challenges and barriers that have hindered widespread adoption of Europe HIV Therapeutics?
Europe HIV Diagnostics Market: Key Players Some of the major Companies dominating the market, by their products and services include AbbVie, Inc., Bristol-Myers Squibb Company, Merck and Co., Inc., and Boehringer Ingelheim GmbH. Gilead Sciences, Inc. was the pioneer in HIV-1 therapeutics sector by considering market share and medication portfolio, took after by ViiV Healthcare in 2015. What's more, in the coming years other little players are required to enter this part with their pipeline drugs.
Reasons to buy Europe HIV Diagnostics Market Report: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
